Reference range(s)
The reference ranges listed below are valid on this date of April 26, 2024.
Component | Age | Male Norm | Male Critical Low | Male Critical High | Female Norm | Female Critical High | Female Critical Low | Units | Add'l info |
---|---|---|---|---|---|---|---|---|---|
Congen Adrenal Hyperplasia (17-OHP) | ALL | See report. | |||||||
Congenital Hypothyroidism (TSH) | ALL | See report. | |||||||
Cystic Fibrosis (IRT) | ALL | See report. | |||||||
Hemoglobinopathy | ALL | See report. | |||||||
Biotinidase | ALL | See report. | |||||||
Galactosemia | ALL | See report. | |||||||
Amino Acid Profile | ALL | See report. | |||||||
Organic Acid Profile | ALL | See report. | |||||||
Fatty Acid Profile | ALL | See report. | |||||||
Severe Combined Immunodeficiency | ALL | *Based on child's... Note1 | |||||||
Glycogen Storage Disorder type II | ALL | See report. | |||||||
Mucopolysaccharidosis type I | ALL | *Based on child's... Note1 |
Note1:
*Based on child's age, birthweight or transfusion statusPlease refer to separate report from Washington State
Department of Health for appropriate reference ranges
The Biotinidase test, SCID test, and analytes screened by
Tandem Mass Spectrometry were developed and their performance characteristics determined by the State of
Washington Public Health Laboratories/ Newborn Screening
Section. They have not been cleared or approved by the FDA
The laboratory is regulated under CLIA as qualified to perform high-complexity testing. These tests are used for screening purposes. They should not be regarded as investigational or for research
See report..